2013 related articles for article (PubMed ID: 12831509)
21. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.
Maiden L; Thjodleifsson B; Seigal A; Bjarnason II; Scott D; Birgisson S; Bjarnason I
Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1040-5. PubMed ID: 17625980
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy induced gastrointestinal toxicity in rats: involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase -2.
Yáñez JA; Teng XW; Roupe KA; Fariss MW; Davies NM
J Pharm Pharm Sci; 2003; 6(3):308-14. PubMed ID: 14738710
[TBL] [Abstract][Full Text] [Related]
23. Ulcerogenicity and effect on inhibition of prostaglandin generation of indometacin farnesil, a prodrug of indomethacin, in rat gastric mucosa: comparison with indomethacin or loxoprofen.
Arakawa T; Fukuda T; Nakagawa K; Higuchi K; Watanabe T; Tominaga K; Kobayashi K
Drugs Exp Clin Res; 1995; 21(3):85-8. PubMed ID: 7555616
[TBL] [Abstract][Full Text] [Related]
24. Protective effects of prostaglandins against nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury.
Dajani EZ; Agrawal NM
Int J Clin Pharmacol Res; 1989; 9(6):359-69. PubMed ID: 2699464
[TBL] [Abstract][Full Text] [Related]
25. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
[TBL] [Abstract][Full Text] [Related]
26. [Application of quantifying scoring systems for the determination of changes in the mucosa of the upper gastrointestinal tract. A comparative study of a diclofenac effervescent tablet with conventional diclofenac preparations and acetylsalicylic acid after repeated administration].
Wildgrube HJ; Kierschke G; Nowak H; Weigmann I; Terhaag B
Arzneimittelforschung; 2002; 52(4):264-72. PubMed ID: 12040969
[TBL] [Abstract][Full Text] [Related]
27. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract.
Sostres C; Gargallo CJ; Arroyo MT; Lanas A
Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):121-32. PubMed ID: 20227026
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of gastric and duodenal damage and protection.
Hudson N; Hawthorne AB; Cole AT; Jones PD; Hawkey CJ
Hepatogastroenterology; 1992 Feb; 39 Suppl 1():31-6. PubMed ID: 1577394
[TBL] [Abstract][Full Text] [Related]
29. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
Fiorucci S; Santucci L; Distrutti E
Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of NSAID-induced gastroduodenal mucosal injury.
Wallace JL
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):691-703. PubMed ID: 11566035
[TBL] [Abstract][Full Text] [Related]
31. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
Agrawal NM; Saggioro A
J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
[TBL] [Abstract][Full Text] [Related]
32. Suppression of growth arrest and DNA damage-inducible 45alpha expression confers resistance to sulindac and indomethacin-induced gastric mucosal injury.
Chiou SK; Hodges A; Hoa N
J Pharmacol Exp Ther; 2010 Sep; 334(3):693-702. PubMed ID: 20498252
[TBL] [Abstract][Full Text] [Related]
33. SKI306X, an oriental herbal mixture, suppresses gastric leukotriene B4 synthesis without causing mucosal injury and the diclofenac-induced gastric lesions.
Kim JH; Rhee HI; Jung IH; Ryu K; Jung K; Han CK; Kwak WJ; Cho YB; Joo HJ
Life Sci; 2005 Jul; 77(11):1181-93. PubMed ID: 15935401
[TBL] [Abstract][Full Text] [Related]
34. Oral glutamine attenuates indomethacin-induced small intestinal damage.
Basivireddy J; Jacob M; Balasubramanian KA
Clin Sci (Lond); 2004 Sep; 107(3):281-9. PubMed ID: 15128285
[TBL] [Abstract][Full Text] [Related]
35. Cyclooxygenase expression and prostanoid production in pyloric and duodenal mucosae in dogs after administration of nonsteroidal anti-inflammatory drugs.
Wooten JG; Blikslager AT; Ryan KA; Marks SL; Law JM; Lascelles BD
Am J Vet Res; 2008 Apr; 69(4):457-64. PubMed ID: 18380576
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
[TBL] [Abstract][Full Text] [Related]
37. Contribution to safe anti-inflammatory therapy with indomethacin.
Bauerová K; Nosál'ová V; Mihalová D; Navarová J
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S8-10. PubMed ID: 15141962
[TBL] [Abstract][Full Text] [Related]
38. Comparative effects of some non-steroidal anti-inflammatory drugs on the ultrastructural integrity and prostaglandin levels in the rat gastric mucosa: relationship to drug uptake.
Rainsford KD; Fox SA; Osborne DJ
Scand J Gastroenterol Suppl; 1984; 101():55-68. PubMed ID: 6443622
[TBL] [Abstract][Full Text] [Related]
39. A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa.
Lanza FL; Royer GL; Nelson RS; Chen TT; Seckman CE; Rack MF
Am J Gastroenterol; 1981 Jan; 75(1):17-21. PubMed ID: 7234826
[TBL] [Abstract][Full Text] [Related]
40. New method of inducing intestinal lesions in rats by intraduodenal administration of aspirin.
Nonoyama K; Nakagawa K; Amagase K; Takeuchi K; Nakamura M; Okabe S
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S15-22. PubMed ID: 20586859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
